MedTrace Logo

Study to Evaluate the Effectiveness and Safety of Libicare® in Women With Low Arousal and Sexual Desire Levels

NCT04188600 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2024-04-04

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effectiveness of Libicare® in the sexual desire and arousal at 12 weeks in peri or postmenopausal women aged between 40 and 60 years old with low sexual desire and arousal compared with active control.

Conditions

  • Female Sexual Interest/Arousal Disorder

Interventions

DIETARY_SUPPLEMENT

Libicare

The main ingredients of Libicare® are: * Trigonella Foenum-graecum (Trigonella) * Tribulus Terrestris (Tribulus) * Turnera Diffusa (Damiana)

DIETARY_SUPPLEMENT

active control

Selenium and vitamins B complex

Sponsors & Collaborators

  • Procare Health Iberia S.L.

    lead INDUSTRY

Principal Investigators

  • Josep Combalia, MD · Procare health Iberia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-14
Primary Completion
2023-11-30
Completion
2023-11-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04188600 on ClinicalTrials.gov